Ligand validation:4NXE

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 4NXE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4NXE_FMN_A_1001	84%	41%	0.098	0.961	1.07	1.23	2	9	0	0	100%	1
4NXE_FMN_B_1001	82%	41%	0.096	0.951	1.08	1.22	2	9	0	0	100%	1
7ABY_FMN_A_500	95%	45%	0.068	0.974	0.96	1.15	2	7	1	0	100%	1
4NXF_FMN_B_1001	88%	43%	0.083	0.958	1.06	1.16	2	8	0	0	100%	1
4NXG_FMN_B_601	72%	42%	0.109	0.932	1.06	1.19	2	7	0	0	100%	1
4NXB_FMN_B_1001	65%	36%	0.139	0.942	1.11	1.4	2	10	2	0	100%	1
4XHF_FMN_C_300	100%	16%	0.024	0.995	2.46	1.29	11	6	0	0	100%	0.9677
9DKQ_FMN_A_1002	100%	42%	0.026	0.997	1.03	1.22	2	7	0	0	100%	1
1QXO_FMN_D_4004	100%	27%	0.025	0.993	1.24	1.7	2	15	1	0	100%	1
5LJI_FMN_A_201	100%	27%	0.025	0.995	1.62	1.33	5	5	0	0	100%	1
9DHG_FMN_A_401	100%	64%	0.027	0.994	0.65	0.73	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.